5-Methylpsilocybin is a psychedelic drug, a synthetic analogue of psilocybin, which has high serotonergic activity.[1][2][3] It produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[1]
| Clinical data | |
|---|---|
| Other names | 5-Methyl-4-phosphoryloxy-N,N-dimethyltryptamine; 5-Me-4-PO-DMT |
| Drug class | Serotonergic psychedelic; Hallucinogen; Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C13H19N2O4P |
| Molar mass | 298.279 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Chemistry
editSynthesis
edit5-Methylpsilocybin can be synthesized by enzymatic phosphorylation of its synthetic precursor, 5-methylpsilocin, using the enzyme 4-hydroxytryptamine kinase purified from Psilocybe cubensis.[1][2]
See also
editReferences
edit- 1 2 3 Fricke, Janis; Sherwood, Alexander M.; Halberstadt, Adam L.; Kargbo, Robert B.; Hoffmeister, Dirk (2021-04-23). "Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity". Journal of Natural Products. 84 (4): 1403–1408. Bibcode:2021JNAtP..84.1403F. doi:10.1021/acs.jnatprod.1c00087. ISSN 1520-6025. PMC 9191645. PMID 33667102.
- 1 2 Umer, Syed Muhammad; Solangi, Mehwish; Khan, Khalid Mohammed; Saleem, Rahman Shah Zaib (2022-11-05). "Indole-Containing Natural Products 2019-2022: Isolations, Reappraisals, Syntheses, and Biological Activities". Molecules (Basel, Switzerland). 27 (21): 7586. doi:10.3390/molecules27217586. ISSN 1420-3049. PMC 9655573. PMID 36364413.
- ↑ Love, David; Jones, Nicole S. (2023). "Interpol Review of Drug Analysis 2019-2022". Forensic Science International. Synergy. 6 100299. doi:10.1016/j.fsisyn.2022.100299. ISSN 2589-871X. PMC 9841213. PMID 36655023.